Literature DB >> 1837777

Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.

M M Ragozzino1, A Kuo, J DeGregori, N Kohl, H E Ruley.   

Abstract

Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 E1A or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837777      PMCID: PMC1568054          DOI: 10.1289/ehp.919397

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  38 in total

Review 1.  Transforming collaborations between ras and nuclear oncogenes.

Authors:  H E Ruley
Journal:  Cancer Cells       Date:  1990 Aug-Sep

2.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Transforming properties of a 15-kDa truncated Ad12 E1A gene product.

Authors:  A G Jochemsen; C M de Wit; J L Bos; A J van der Eb
Journal:  Virology       Date:  1986-07-30       Impact factor: 3.616

4.  Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells.

Authors:  B Zerler; B Moran; K Maruyama; J Moomaw; T Grodzicker; H E Ruley
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

5.  Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a.

Authors:  M Kuppuswamy; T Subramanian; G Chinnadurai
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

6.  In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes.

Authors:  B R Franza; K Maruyama; J I Garrels; H E Ruley
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

7.  Synthesis of p34, the mammalian homolog of the yeast cdc2+/CDC28 protein kinase, is stimulated during adenovirus-induced proliferation of primary baby rat kidney cells.

Authors:  G Draetta; D Beach; E Moran
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

8.  Conditional immortalization and/or transformation of rat cells carrying v-abl or EJras oncogene in the presence or absence of glucocorticoid hormone.

Authors:  T Yamashita; H Kato; K Fujinaga
Journal:  Int J Cancer       Date:  1988-12-15       Impact factor: 7.396

9.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

10.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.

Authors:  J F Schneider; F Fisher; C R Goding; N C Jones
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  3 in total

1.  Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts.

Authors:  Minna Thullberg; Annica Gad; Sylvie Le Guyader; Staffan Strömblad
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

2.  ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Authors:  Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey
Journal:  Carcinogenesis       Date:  2015-04-27       Impact factor: 4.944

3.  E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.

Authors:  María Llanos Valero; Francisco Jose Cimas; Laura Arias; Pedro Melgar-Rojas; Elena García; Juan Luis Callejas-Valera; Jesús García-Cano; Leticia Serrano-Oviedo; Miguel Ángel de la Cruz-Morcillo; Isabel Sánchez-Pérez; Ricardo Sánchez-Prieto
Journal:  Cell Cycle       Date:  2013-10-11       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.